Giving Patients Power Over Their Skin

Inspired by the Goeckerman Regimen: The Science Behind illuvinate

The illuvinate System is a new and innovative psoriasis treatment inspired by the Goeckerman Regimen, a clinically-proven regimen introduced over 100 years ago by a dermatologist at the Mayo Clinic.

In addition to being effective, the Goeckerman Regimen is safe and low-risk compared to other treatment options like topical steroids and biologics.

Patient with psoriasis getting an occlusive wrap with coal tar during Goeckerman Therapy
Patient entering a UVB light chamber during Goeckerman Therapy

Evidence Supporting Goeckerman Regimen

Study of Modern Goeckerman Regimen1

  • Patients with psoriasis that are resistant to other therapies (like injections)
  • 12 weeks of Goeckerman regimen treatments
  • 100% of patients achieved at least a 75% improvement in psoriasis

1Ref: Pubmed 16019624

Published Study with 300 Patients2

  • Average time to achieve 90% clearance in psoriasis was only 18 days
  • 90% of those patients were clear after 8 months
  • 73% remained clear after 1 year or more

2Ref: Pubmed 6886105


of the 26 patients in the 3rd clinical trial experienced meaningful clearance at 6 weeks

Illuvinate Clinical Trials

Three clinical trials, including feasibility and efficacy trials, were conducted for illuvinate, treating patients with moderate-to-severe psoriasis. Of the 26 patients in the 3rd clinical trial, 92% of them saw meaningful clearance of psoriasis plaques at 6 weeks. Patients continued to see improvements after completing the 6-week treatment.

“The illuvinate System was inspired by the Goeckerman Regimen and I’ve been encouraged by the strong clinical data supporting its use in the home for plaque psoriasis. It is easy to use and convenient. It has the potential to help millions of people suffering from psoriasis.”

– Dr. Jeff Sugarman, MD PhD, Principal Investigator

Case Study: Georgios K.